Stručni rad - Pismo uredniku
Remdesivir for COVID-19 pneumonia: still undecided, but it might all be about adequate timing
European Journal of Clinical Pharmacology, 77 (2021), 6; 935-937. https://doi.org/10.1007/s00228-020-03085-7


Povezani objekti
COVID-19 | Virtualna zbirka
Citirajte ovaj rad

Trkulja, V. (2021). Remdesivir for COVID-19 pneumonia: still undecided, but it might all be about adequate timing. European Journal of Clinical Pharmacology, 77. (6), 935-937. doi: 10.1007/s00228-020-03085-7

Trkulja, Vladimir. "Remdesivir for COVID-19 pneumonia: still undecided, but it might all be about adequate timing." European Journal of Clinical Pharmacology, vol. 77, br. 6, 2021, str. 935-937. https://doi.org/10.1007/s00228-020-03085-7

Trkulja, Vladimir. "Remdesivir for COVID-19 pneumonia: still undecided, but it might all be about adequate timing." European Journal of Clinical Pharmacology 77, br. 6 (2021): 935-937. https://doi.org/10.1007/s00228-020-03085-7

Trkulja, V. (2021) 'Remdesivir for COVID-19 pneumonia: still undecided, but it might all be about adequate timing', European Journal of Clinical Pharmacology, 77(6), str. 935-937. doi: 10.1007/s00228-020-03085-7

Trkulja V. Remdesivir for COVID-19 pneumonia: still undecided, but it might all be about adequate timing. European Journal of Clinical Pharmacology [Internet]. 06.01.2021. [pristupljeno 27.11.2021.];77(6):935-937. doi: 10.1007/s00228-020-03085-7

V. Trkulja, "Remdesivir for COVID-19 pneumonia: still undecided, but it might all be about adequate timing", European Journal of Clinical Pharmacology, vol. 77, br. 6, str. 935-937, Siječanj 2021. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:105:524286. [Citirano: 27.11.2021.]

Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.